Breast cancer cells rely on environmental pyruvate to shape the metastatic niche.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
04 2019
Historique:
received: 01 11 2017
accepted: 28 01 2019
pubmed: 1 3 2019
medline: 20 8 2019
entrez: 1 3 2019
Statut: ppublish

Résumé

The extracellular matrix is a major component of the local environment-that is, the niche-that determines cell behaviour

Identifiants

pubmed: 30814728
doi: 10.1038/s41586-019-0977-x
pii: 10.1038/s41586-019-0977-x
pmc: PMC6451642
mid: EMS81520
doi:

Substances chimiques

Ketoglutaric Acids 0
Pyruvic Acid 8558G7RUTR
Collagen 9007-34-5
Procollagen-Proline Dioxygenase EC 1.14.11.2

Types de publication

Journal Article

Langues

eng

Pagination

117-121

Commentaires et corrections

Type : CommentIn

Références

Methods Mol Biol. 2019;1862:53-66
pubmed: 30315459
Biochim Biophys Acta. 1995 Aug 17;1245(1):43-8
pubmed: 7544626
Nat Rev Mol Cell Biol. 2014 Dec;15(12):786-801
pubmed: 25415508
Breast. 2013 Aug;22 Suppl 2:S66-72
pubmed: 24074795
Methods Mol Biol. 2019;1862:67-82
pubmed: 30315460
Metab Eng. 2017 Sep;43(Pt B):187-197
pubmed: 27847310
Cell. 2017 Oct 5;171(2):358-371.e9
pubmed: 28985563
Biol Cell. 2015 Aug;107(8):251-72
pubmed: 25913226
Nat Commun. 2017 May 11;8:15267
pubmed: 28492237
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20009-14
pubmed: 21041659
Cell Stem Cell. 2016 Apr 7;18(4):541-53
pubmed: 26971820
Cell Rep. 2016 Oct 11;17(3):837-848
pubmed: 27732858
Biotechniques. 1997 Apr;22(4):656-8
pubmed: 9105617
Curr Opin Biotechnol. 2015 Aug;34:189-201
pubmed: 25731751
BMC Cancer. 2014 Jan 02;14:1
pubmed: 24383403
Nature. 2019 Jan;565(7740):511-515
pubmed: 30651640
Cell. 2014 Oct 23;159(3):647-61
pubmed: 25307932
Trends Cell Biol. 2018 Aug;28(8):673-684
pubmed: 29747903
Breast Cancer Res. 2018 Jul 13;20(1):76
pubmed: 30005601
Cancer Res. 2013 Jun 1;73(11):3285-96
pubmed: 23539444
Nat Rev Cancer. 2014 Jun;14(6):430-9
pubmed: 24827502

Auteurs

Ilaria Elia (I)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.

Matteo Rossi (M)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.

Steve Stegen (S)

Laboratory of Clinical and Experimental Endocrinology, Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium.

Dorien Broekaert (D)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.

Ginevra Doglioni (G)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.

Marit van Gorsel (M)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.

Ruben Boon (R)

Stem Cell Institute, KU Leuven, Leuven, Belgium.

Carmen Escalona-Noguero (C)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.

Sophie Torrekens (S)

Laboratory of Clinical and Experimental Endocrinology, Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium.

Catherine Verfaillie (C)

Stem Cell Institute, KU Leuven, Leuven, Belgium.

Erik Verbeken (E)

Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium.

Geert Carmeliet (G)

Laboratory of Clinical and Experimental Endocrinology, Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium.

Sarah-Maria Fendt (SM)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium. sarah-maria.fendt@kuleuven.vib.be.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium. sarah-maria.fendt@kuleuven.vib.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH